143 related articles for article (PubMed ID: 38506663)
1. Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell Sensitivities.
Goldfarb RB; Atala Pleshinger MJ; Yan DF; Adams DJ
ACS Chem Biol; 2024 Apr; 19(4):896-907. PubMed ID: 38506663
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
3. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
[TBL] [Abstract][Full Text] [Related]
4. Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.
Boppana NB; Kraveka JM; Rahmaniyan M; Li LI; Bielawska A; Bielawski J; Pierce JS; Delor JS; Zhang K; Korbelik M; Separovic D
Anticancer Res; 2017 Feb; 37(2):455-463. PubMed ID: 28179290
[TBL] [Abstract][Full Text] [Related]
5. Ceramide signaling in fenretinide-induced endothelial cell apoptosis.
Erdreich-Epstein A; Tran LB; Bowman NN; Wang H; Cabot MC; Durden DL; Vlckova J; Reynolds CP; Stins MF; Groshen S; Millard M
J Biol Chem; 2002 Dec; 277(51):49531-7. PubMed ID: 12388538
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
7. Enhanced apoptotic cancer cell killing after Foscan photodynamic therapy combined with fenretinide via de novo sphingolipid biosynthesis pathway.
Boppana NB; DeLor JS; Van Buren E; Bielawska A; Bielawski J; Pierce JS; Korbelik M; Separovic D
J Photochem Photobiol B; 2016 Jun; 159():191-5. PubMed ID: 27085050
[TBL] [Abstract][Full Text] [Related]
8. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis.
Bikman BT; Guan Y; Shui G; Siddique MM; Holland WL; Kim JY; Fabriàs G; Wenk MR; Summers SA
J Biol Chem; 2012 May; 287(21):17426-17437. PubMed ID: 22474281
[TBL] [Abstract][Full Text] [Related]
9. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
10. Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity.
Rehman F; Shanmugasundaram P; Schrey MP
Br J Cancer; 2004 Nov; 91(10):1821-8. PubMed ID: 15505623
[TBL] [Abstract][Full Text] [Related]
11. N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing.
Wang H; Maurer BJ; Liu YY; Wang E; Allegood JC; Kelly S; Symolon H; Liu Y; Merrill AH; Gouazé-Andersson V; Yu JY; Giuliano AE; Cabot MC
Mol Cancer Ther; 2008 Sep; 7(9):2967-76. PubMed ID: 18790777
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production.
Andrews WJ; Winnett G; Rehman F; Shanmugasundaram P; Hagen Dv; Schrey MP
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):159-65. PubMed ID: 15862961
[TBL] [Abstract][Full Text] [Related]
14. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
15. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
16. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
Jang Y; Rao X; Jiang Q
J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
[TBL] [Abstract][Full Text] [Related]
17. Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.
Apraiz A; Idkowiak-Baldys J; Nieto-Rementería N; Boyano MD; Hannun YA; Asumendi A
Biochem Cell Biol; 2012 Apr; 90(2):209-23. PubMed ID: 22428532
[TBL] [Abstract][Full Text] [Related]
18. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
[TBL] [Abstract][Full Text] [Related]
20. Preferential involvement of both ROS and ceramide in fenretinide-induced apoptosis of HL60 rather than NB4 and U937 cells.
Jiang L; Pan X; Chen Y; Wang K; Du Y; Zhang J
Biochem Biophys Res Commun; 2011 Feb; 405(2):314-8. PubMed ID: 21237137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
